TL
Telix Pharmaceuticals Limited (TLX)
NASDAQ·Healthcare·Biotechnology
$9.66
+2.55%
Mkt Cap $2.54B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$18.00
Range $18.00 – $18.00
Implied Upside
+86.3%
Consensus $18.00 vs current $9.66
NASDAQ·Healthcare·Biotechnology
$9.66
+2.55%
Mkt Cap $2.54B
No recent rating data.
Price Target (4 analysts)
$18.00
Range $18.00 – $18.00
+86.3%
Consensus $18.00 vs current $9.66